Metoprolol compared to carvedilol deteriorates insulin-stimulated endothelial function in patients with type 2 diabetes - a randomized study. - Wikidata - awgldk - TriplyDB

Metoprolol compared to carvedilol deteriorates insulin-stimulated endothelial function in patients with type 2 diabetes - a randomized study.

Metoprolol compared to carvedilol deteriorates insulin-stimulated endothelial function in patients with type 2 diabetes - a randomized study.

http://www.wikidata.org/entity/Q33945028

about

Novel treatment approaches in hypertensive type 2 diabetic patients The current status of beta blockers' use in the management of hypertension Endothelial function is unaffected by changing between carvedilol and metoprolol in patients with heart failure--a randomized study.Beta blocker use in subjects with type 2 diabetes mellitus and systolic heart failure does not worsen glycaemic control.Use of carvedilol in hypertension: an update.Choice of anti-hypertensive agents in diabetic subjects.The glycemic effects of antihypertensive medications.THE IMPACT OF CARDIOVASCULAR DRUGS ON GLYCEMIC CONTROL: A REVIEW.Effects of Carvedilol Compared to Nebivolol on Insulin Resistance and Lipid Profile in Patients With Essential Hypertension.Ivabradine and metoprolol differentially affect cardiac glucose metabolism despite similar heart rate reduction in a mouse model of dyslipidemia.

P2860

Q34023579-BF7A852F-4BEC-491E-8C15-95768982DB87 Q35183592-A8F3BF32-F339-4529-801A-AF8AB6386F3E Q35540707-8CAA1C80-3923-49FD-B929-78FA08EE2E71 Q35818321-EC05B94C-EB5A-40F2-8A81-76A9238BBE75 Q35997307-6E1B745F-2A2A-44E0-A6C4-0DBD8E43506C Q38118047-5050AEEB-7D0E-4E41-9574-F0EA75B3581B Q38171389-2FF1F1AF-51E3-410B-932E-E3ABC36D7B1C Q39038196-F5003777-D21D-415C-B954-C2AB3BC17DD1 Q51285745-FFCBA2C5-82DA-40ED-A0B2-8FD7768F43AB Q51590601-FF489210-CBF7-42B7-A28A-F5C8C3F011BC

P2860

Metoprolol compared to carvedilol deteriorates insulin-stimulated endothelial function in patients with type 2 diabetes - a randomized study.

http://www.wikidata.org/entity/Q33945028

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Metoprolol compared to carvedi ...... diabetes - a randomized study.

@ast

Metoprolol compared to carvedi ...... diabetes - a randomized study.

@en

type

label

Metoprolol compared to carvedi ...... diabetes - a randomized study.

@ast

Metoprolol compared to carvedi ...... diabetes - a randomized study.

@en

prefLabel

Metoprolol compared to carvedi ...... diabetes - a randomized study.

@ast

Metoprolol compared to carvedi ...... diabetes - a randomized study.

@en

P1433

Q33945028-0F1B79EB-0E4E-4B7A-A8D0-40CC985791E2

P1476

Q33945028-783C1243-8770-49A6-8267-0732D5520A16

P2093

Q33945028-053B5677-0C43-4034-A55D-583F1D54908A

Q33945028-6D4AD35A-E2E2-4C00-91DA-6F2761A54F22

Q33945028-9CB3C83A-0592-431C-96B3-08A23192E3E3

Q33945028-D1E56DF0-348A-44C6-9C29-CC2851A3FE7E

Q33945028-DD5EA97E-FF5A-462A-AE69-58ADD962B3CF

Q33945028-F850EE32-E557-40A2-837B-DAF1A08DD7D9

P2860

Q33945028-0408C47B-9DA3-4D0F-BAC7-D080C944F3CC

Q33945028-0E931455-CD24-43A9-92C3-6A87A4120CD8

Q33945028-112A7A7D-BD27-4EB2-A231-F1F908855F31

Q33945028-27931664-8A03-4D2C-90FD-8A8D856696EC

Q33945028-35BF884E-B0E9-4135-896D-E74764EFF477

Q33945028-3A57E12D-E6A1-4AAC-A3A7-7D223AF939D5

Q33945028-416B9234-9950-48FE-A045-8675022F75B5

Q33945028-45E6B3C7-F638-4EDD-A147-B309D9B49668

Q33945028-47201EBB-F2A0-479F-91EA-C9FE261AB405

Q33945028-4814957B-61AC-4D89-ABBA-BA9102DCC74B

P2888

Q33945028-507C6B2C-CEEC-4869-90B4-84E3B46D2CBC

P304

Q33945028-32495C72-460D-4B2F-9D30-C20640E6AFB8

P31

Q33945028-F380A03F-CB40-4483-B8E2-2822CBC6A1EA

P356

Q33945028-03EC2605-3FDB-479B-B8C6-57CF0CD3BE8F

P407

Q33945028-7DDE13D8-4A0A-41CD-A131-254B44BB8F31

P478

Q33945028-2F3DCB62-8429-431B-AFE3-E5EB99FED946

P50

Q33945028-31C2AA3A-33F5-4709-AF96-7C5D84824BFD

Q33945028-7DDF24D3-5E52-496F-A0E2-D87F66F23C92

Q33945028-B50A966A-054F-4000-B670-ED84A78FA9AE

P577

Q33945028-0A8A0715-89F0-47C4-8367-993B5FAC6C76

P5875

Q33945028-333DA761-F812-4254-8400-341951FCE7AF

P6179

Q33945028-3EA5A919-067A-4925-B674-33E58220F129

P698

Q33945028-8DE3973F-037B-4C5B-A708-1A32D16EB119

P921

Q33945028-26F067D3-D8E1-4A59-9AD8-59A4E3567764

Q33945028-6FB3EA96-5719-4AE1-9EF8-224E029B91F3

Q33945028-7111D341-442C-4666-A27B-EA53892F2347

P932

Q33945028-AFAE97EE-C1A4-4835-9AF8-8E87C2133C15

P356

P1433

Cardiovascular Diabetology

P1476

Metoprolol compared to carvedi ...... diabetes - a randomized study.

@en

P2093

Atheline Major-Pedersen

http://www.w3.org/2001/XMLSchema#string

Britt Kveiborg

http://www.w3.org/2001/XMLSchema#string

Buris Christiansen

http://www.w3.org/2001/XMLSchema#string

Christian Rask-Madsen

http://www.w3.org/2001/XMLSchema#string

Jakob Raunsø

http://www.w3.org/2001/XMLSchema#string

Thomas S Hermann

http://www.w3.org/2001/XMLSchema#string

P2860

Atherosclerosis — An Inflammatory Disease

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Adiponectin and future coronary heart disease events among men with type 2 diabetes

Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET).

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial.

Pathophysiology of oxidative stress in diabetes mellitus.

Use of beta-blockers in obesity hypertension: potential role of weight gain.

Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients.

Methodological aspects, dose-response characteristics and causes of interindividual variation in insulin stimulation of limb blood flow in normal subjects.

Beta-blockers have a beneficial effect upon endothelial function and microalbuminuria in African-American subjects with diabetes and hypertension.

P2888

P304

21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1475-2840-9-21

http://www.w3.org/2001/XMLSchema#string

P407

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Christian Torp-Pedersen

Helena Dominguez

P577

2010-05-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44628812

http://www.w3.org/2001/XMLSchema#string

P6179

1003957469

http://www.w3.org/2001/XMLSchema#string

P698

20500877

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

2893119

http://www.w3.org/2001/XMLSchema#string